Form 8-K - Current report:
SEC Accession No. 0001564590-20-022376
Filing Date
2020-05-07
Accepted
2020-05-07 07:46:00
Documents
2
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K torc-8k_20200507.htm 8-K 41812
2 EX-99.1 torc-ex991_7.htm EX-99.1 164947
  Complete submission text file 0001564590-20-022376.txt   207883
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 20854614
SIC: 2834 Pharmaceutical Preparations